Two Sigma Advisers’s Colgate-Palmolive CL Stock Holding History

Two Sigma Advisers’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-604,400	Closed	-$47.8M	–	434
2025 Q4	$47.8M	Sell	604,400 -809,100	-57%	-$63.4M	0.09%	189
2025 Q3	$113M	Buy	1,413,500 +1,282,700	+981%	+$109M	0.23%	103
2025 Q2	$11.9M	Sell	130,800 -763,800	-85%	-$69.7M	0.02%	455
2025 Q1	$83.8M	Buy	894,600 +723,700	+423%	+$64.8M	0.19%	115
2024 Q4	$15.5M	Buy	170,900 +126,300	+283%	+$12.1M	0.04%	381
2024 Q3	$4.63M	Sell	44,600 -25,300	-36%	-$2.58M	0.01%	727
2024 Q2	$6.78M	Sell	69,900 -60,100	-46%	-$5.54M	0.02%	658
2024 Q1	$11.7M	Sell	130,000 -2,417,800	-95%	-$205M	0.03%	488
2023 Q4	$203M	Buy	2,547,800 +835,800	+49%	+$62.8M	0.48%	50
2023 Q3	$122M	Sell	1,712,000 -1,559,200	-48%	-$117M	0.31%	78
2023 Q2	$252M	Buy	3,271,200 +916,700	+39%	+$71M	0.64%	31
2023 Q1	$177M	Buy	2,354,500 +1,281,000	+119%	+$95.3M	0.46%	55
2022 Q4	$84.6M	Sell	1,073,500 -223,300	-17%	-$16.7M	0.24%	95
2022 Q3	$91.1M	Buy	1,296,800 +721,700	+125%	+$56.6M	0.26%	94
2022 Q2	$46.1M	Sell	575,100 -751,300	-57%	-$58.7M	0.13%	170
2022 Q1	$101M	Buy	1,326,400 +773,600	+140%	+$61.3M	0.27%	84
2021 Q4	$47.2M	Buy	552,800 +497,800	+905%	+$38.9M	0.12%	165
2021 Q3	$4.16M	Buy	55,000 +47,100	+596%	+$3.74M	0.01%	882
2021 Q2	$643K	Buy	7,900 +1,400	+22%	+$114K	﹤0.01%	1831
2021 Q1	$512K	Sell	6,500 -10,100	-61%	-$792K	﹤0.01%	2011
2020 Q4	$1.42M	Sell	16,600 -1,031,900	-98%	-$85.3M	﹤0.01%	1418
2020 Q3	$80.9M	Buy	1,048,500 +626,100	+148%	+$47.7M	0.23%	102
2020 Q2	$30.9M	Sell	422,400 -105,900	-20%	-$7.52M	0.09%	231
2020 Q1	$35.1M	Buy	528,300 +434,689	+464%	+$30.7M	0.13%	179
2019 Q4	$6.44M	Sell	93,611 -1,608,200	-94%	-$110M	0.02%	743
2019 Q3	$125M	Sell	1,701,811 -732,700	-30%	-$53.2M	0.31%	85
2019 Q2	$174M	Sell	2,434,511 -68,600	-3%	-$4.87M	0.43%	44
2019 Q1	$172M	Sell	2,503,111 -929,100	-27%	-$60M	0.43%	52
2018 Q4	$204M	Sell	3,432,211 -806,500	-19%	-$50.5M	0.56%	29
2018 Q3	$284M	Sell	4,238,711 -102,200	-2%	-$6.81M	0.69%	16
2018 Q2	$281M	Buy	4,340,911 +717,100	+20%	+$46.9M	0.76%	10
2018 Q1	$260M	Buy	3,623,811 +2,110,100	+139%	+$152M	0.7%	12
2017 Q4	$114M	Buy	1,513,711 +303,690	+25%	+$22.2M	0.31%	86
2017 Q3	$88.2M	Buy	1,210,021 +121,421	+11%	+$8.75M	0.25%	107
2017 Q2	$80.7M	Sell	1,088,600 -1,355,465	-55%	-$101M	0.27%	88
2017 Q1	$179M	Sell	2,444,065 -485,142	-17%	-$34M	0.59%	20
2016 Q4	$192M	Buy	2,929,207 +1,540,536	+111%	+$106M	0.73%	10
2016 Q3	$103M	Sell	1,388,671 -347,314	-20%	-$25.7M	0.44%	52
2016 Q2	$127M	Sell	1,735,985 -415,200	-19%	-$29.6M	0.65%	27
2016 Q1	$152M	Buy	2,151,185 +252,652	+13%	+$16.8M	0.85%	12
2015 Q4	$126M	Buy	1,898,533 +131,164	+7%	+$8.73M	0.75%	20
2015 Q3	$112M	Buy	1,767,369 +1,609,618	+1,020%	+$105M	0.71%	22
2015 Q2	$10.3M	Buy	+157,751	New	+$10.7M	0.08%	290
2014 Q4	–	Sell	-522,071	Closed	-$34M	–	2458
2014 Q3	$34M	Buy	+522,071	New	+$34.4M	0.26%	94
2014 Q1	–	Sell	-4,071	Closed	-$257K	–	2293
2013 Q4	$266K	Sell	4,071 -47,400	-92%	-$3.03M	﹤0.01%	1969
2013 Q3	$3.05M	Sell	51,471 -12,685	-20%	-$752K	0.04%	459
2013 Q2	$3.67M	Buy	+64,156	New	+$3.81M	0.05%	313

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Two Sigma Advisers's CL Position: Q1 2026 in Review

Two Sigma Advisers sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 604,400 shares — an estimated $47.8M sold.

Two Sigma Advisers first reported a position in CL in Q2 2013 and held it in 47 quarters. The position peaked at $284M in Q3 2018. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Two Sigma Advisers reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
Two Sigma Advisers sold 604,400 Colgate-Palmolive shares in Q1 2026, an estimated $47.8M.
Two Sigma Advisers first reported a position in Colgate-Palmolive in Q2 2013 and held it in 47 quarters.
Two Sigma Advisers's Colgate-Palmolive position peaked at $284M in Q3 2018.
1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.